跳至主要内容
临床试验/NCT04473989
NCT04473989Unknown2 期

The Effect of Weekly Injection of Teriparatide on the Healing of Distal Radius Fracture in a Double-blind, Randomized Controlled Clinical Trial

Peking University Third Hospital0 个研究点目标入组 80 人开始时间: 2021年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
80
主要终点
The median time of radiographic healing

研究概览

简要总结

The purpose of this study is to examine the effect of weekly dosing strategy on fracture healing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Postmenopausal women aged 45-75 (at least 2 years after menopause)
  • With primary osteoporosis
  • Patients with Colles fractures with a fracture time of no more than 7 days
  • conservative treatment after fracture (closed reduction and immobilization)
  • no multiple fractures
  • Informed well and agree to participate in this clinical trial

排除标准

  • Combine other physical diseases, including diabetes, severe hypertension, autoimmune diseases, heart, liver and kidney diseases, malignant tumors, mental illnesses, and other diseases that doctors believe may affect the healing process.
  • In addition to primary osteoporosis, any disease affecting bone metabolism or treatment response, including serum PTH>65pg/ml, 25-hydroxyvitamin D<20ng/ml, alkaline phosphatase>135U/L, history of bone tumor, Paget disease, history of radiotherapy
  • The fracture site has a history of trauma or surgery, affecting the function of the wrist or forearm
  • Those who are allergic to PTH or any excipients
  • Currently receiving anti-osteoporosis treatment or receiving other anti-osteoporosis treatment during the trial
  • Contraindication of teriparatide including hyperparathyroidism, severe renal insufficiency, hypercalcemia, etc.

研究组 & 干预措施

Placebo

Placebo Comparator

Injection product without active teriparatide

干预措施: Placebo (Drug)

PTH 40ug/w

Experimental

Injection product with active teriparatide

干预措施: recombinant teriparatide for injection (Drug)

结局指标

主要结局

The median time of radiographic healing

时间窗: 0-14 weeks

A score of 13 by Modified Radiographic Union Scale for Tibia fractures (mRUST) scoring system would provide a confident assessment of union

次要结局

  • Patient-Rated Wrist Evaluation(0, 4, 6, 8, 10, 12, 14 and 16 weeks)
  • Grip strength(6, 8, 10, 12, 14, and 16 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Weekly Use of Teriparatide to Accelerate Healing of... | 临床试验